Biomea Fusion

BMEANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$42.584 M

$0.59 -3.99%

Close of 6 Nov 2026

As of 6 Nov 2026, Biomea Fusion (BMEA) has a market capitalization of $42.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$61.8M

Loss-making

Shares outstanding

72,483,852

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#343Connect BiopharmaCNTB$46.0M
#344Mereo BioPharma GroupMREO$45.0M
#345Biomea FusionBMEA$42.6M
#346Gain TherapeuticsGANX$42.1M
#347Alterity TherapeuticsATHE$41.5M

What if Biomea Fusion were worth as much as…

Open the what-if tool →

Gold $28.2T

$389,560.89

Per share 663,082× higher

Bitcoin $1.53T

$21,078.46

Per share 35,878× higher

Apple $5.02T

$69,198.62

Per share 117,785× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for Biomea Fusion are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.